Can you inject Mounjaro above the belly button?

You've just clicked the cap off your pen and you're not sure where to press it

It's a small, practical question that matters more than it sounds. You've been told 'the stomach' or 'the abdomen', and you're looking down wondering whether above the belly button counts, whether it's the same as below, and whether getting this wrong will cause a problem.

The licensed guidance for tirzepatide, detailed in the Mounjaro SmPC published on the electronic Medicines Compendium, confirms three acceptable sites: abdomen, thigh and upper arm. Within the abdomen, the instruction is to avoid injecting directly into the navel or the skin immediately surrounding it, typically interpreted as roughly 2 to 3 centimetres clear on all sides. Beyond that exclusion zone, both the area above the navel and the area below it are acceptable. Most people find a spot either side of the midline, a few centimetres above the waist, or lower on the belly, all within the licensed zone.

The reason the navel itself is excluded is practical: the skin there is thicker and more fibrous, absorption is less predictable, and the area has poorer vascularity for subcutaneous delivery. A centimetre or two of clearance, and you're on suitable tissue again. The Mounjaro SmPC on the eMC is the definitive reference if you want to read the exact wording for yourself.

Why rotating matters as much as where you start

Picking above the belly button once is fine. Injecting into precisely the same spot above the belly button every single week is where problems begin.

Repeated injections into identical tissue cause a condition called lipohypertrophy, a build-up of scar-like fatty tissue under the skin. It isn't dangerous in itself, but it changes how the medicine is absorbed, and that inconsistency can blunt the effect over time. It also tends to become numb, which makes it tempting to keep using (it hurts less), which deepens the problem.

The solution is a deliberate rotation pattern. Most people divide their abdomen into four rough quadrants, move between them week to week, and keep each individual injection point at least a centimetre from the previous one in the same area. If you also use your thigh or upper arm (which is worth considering if your abdomen needs a break) rotate between those sites too. The injection accessories page covers sharps disposal and swabs if you need a practical refresher on the full prep routine.

One detail worth knowing: if you inject into the upper arm, you will generally need someone to help, or to use a mirror; the pen requires a steady, flat press against the skin. The abdomen and outer thigh are easier to self-administer with confidence.

How injection technique connects to belly-area results

A question our prescribers hear regularly is whether injecting near the stomach area speeds up fat loss there specifically. The honest answer is no: tirzepatide works systemically through the bloodstream, not locally at the injection site. Where you inject affects absorption consistency; it doesn't direct the medicine to that patch of tissue. The way tirzepatide influences body composition is through the whole-body hormonal effects of GIP and GLP-1 receptor activation, appetite reduction and, over time, the metabolic shift that comes with sustained weight loss, and if you want to understand whether Mounjaro actually gets rid of belly fat, that page looks at the evidence in detail. If you're also curious about how Mounjaro targets belly fat specifically, that page explores the topic in more depth. If you're also looking for practical steps to support the process, the guide on how to lose belly fat on Mounjaro pairs well with it. If you're curious about the mechanism in more depth, the tirzepatide overview covers how the dual-agonist pathway works.

Proper technique does matter for a different reason: a poorly performed injection (angled wrong, into skin that's tense rather than relaxed, or not held long enough) can lead to leakage, incomplete dosing or unnecessary bruising. The NHS patient information for tirzepatide includes a step-by-step guide; the NHS medicines page for tirzepatide is a reliable plain-English reference alongside your own leaflet.

What to do if your injection site feels sore or looks different

Some mild redness or a small raised area immediately after injecting is normal and usually fades within a few hours. A bruise that appears over the following day is also common, particularly if a small capillary was nicked. Neither should alarm you.

What warrants a conversation with your prescriber: a lump or hardened area that persists beyond a week or two; redness that spreads rather than fades; warmth, swelling or pain that feels disproportionate; or any sign of infection such as heat or discharge. These are unusual but worth reporting through your aftercare contact rather than waiting. You can also use the contact page to reach the team directly.

Separately, if you experience stomach pain that's severe and doesn't ease, that's a different kind of concern: the MHRA flagged acute pancreatitis as a known, infrequent but serious risk for GLP-1 medicines in early 2026, severe, persistent abdominal pain that radiates to the back needs urgent medical attention, not a message to your pharmacy. The guide to stomach ache on Mounjaro separates the minor from the urgent if you want more detail.

When you receive your pen from nume (it comes via DPD in plain unbranded packaging, with tracking to your phone) the box contains the Patient Information Leaflet with full injection instructions. If anything in there raises a question, the prescribing team is available seven days a week. If you'd like to discuss whether tirzepatide is clinically suitable for you, check your eligibility through a free consultation.